J. zur Megede

发表

Enhancement of DNA vaccine potency in rhesus macaques by electroporation.

Mark G. Lewis, J. Ulmer, J. Donnelly, 2004, Vaccine.

Reverse transcriptase activity and particle production in B lymphoblastoid cell lines established from lymphocytes of patients with multiple sclerosis.

K. Boller, T. Christensen, J. Z. Megede, 1999, AIDS research and human retroviruses.

Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge.

D. Watkins, J. Altman, R. Kurth, 2002, The Journal of general virology.

Characterization of the South African HIV type 1 subtype C complete 5' long terminal repeat, nef, and regulatory genes.

T. Scriba, S. Barnett, S. Engelbrecht, 2002, AIDS research and human retroviruses.

Infection of Human Dendritic Cells by a Sindbis Virus Replicon Vector Is Determined by a Single Amino Acid Substitution in the E2 Glycoprotein

D. Driver, M. L. Mackichan, B. Belli, 2000, Journal of Virology.

Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles.

P. Luciw, J. Donnelly, C. Greer, 2006, AIDS research and human retroviruses.

β7‐integrin‐independent enhancement of mucosal and systemic anti‐HIV antibody responses following combined mucosal and systemic gene delivery

P. Luciw, J. Donnelly, Manmohan J. Singh, 2007, Immunology.

Long‐term Protection in Hamsters against Human Parainfluenza Virus Type 3 Following Mucosal or Combinations of Mucosal and Systemic Immunizations with Chimeric Alphavirus‐based Replicon Particles

Y. Uematsu, C. Greer, J. Polo, 2007, Scandinavian journal of immunology.

Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host.

R. Kurth, S. Norley, J. Denner, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo.

R. Kurth, S. Norley, M. Baier, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 gag Gene

Mary Schaefer, Mark Selby, C. Greer, 2000, Journal of Virology.

Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype B pol and gagpol DNA Vaccines

J. Ulmer, J. Donnelly, Hong Liu, 2003, Journal of Virology.

Why are the natural hosts of SIV resistant to AIDS?

R. Kurth, S. Norley, J. Z. Megede, 1999, Immunology letters.

Novel evolutionary analyses of full-length HIV type 1 subtype C molecular clones from Cape Town, South Africa.

T. de Oliveira, T. Scriba, S. Barnett, 2002, AIDS research and human retroviruses.

Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.

J. Levy, S. Staprans, S. Shiboski, 2004, Vaccine.

Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.

T. Scriba, S. Barnett, R. Glashoff, 2005, Vaccine.

Gp120 stability on HIV-1 virions and Gag-Env pseudovirions is enhanced by an uncleaved Gag core.

P. Spearman, Xuemin Chen, S. Barnett, 2003, Virology.

Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain

D. Montefiori, P. Luciw, J. Ulmer, 2005, Journal of Virology.

A therapeutic SIV DNA vaccine elicits T-cell immune responses, but no sustained control of viremia in SIVmac239-infected rhesus macaques.

Brigitte E. Sanders-Beer, J. Ulmer, J. Donnelly, 2008, AIDS research and human retroviruses.

Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein in MF59 Adjuvant

J. Ulmer, J. Donnelly, I. Srivastava, 2010, Journal of Virology.

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

J. Ulmer, J. Donnelly, Manmohan J. Singh, 2003, Journal of Virology.

Quantitative assessment of antigen-specific CD8+ T cells in the mouse: application to vaccine research.

J. Ulmer, G. Otten, S. Barnett, 2003, Immunology letters.

Variability at Human Immunodeficiency Virus Type 1 Subtype C Protease Cleavage Sites: an Indication of Viral Fitness?

Tulio de Oliveira, Susan Engelbrecht, T. de Oliveira, 2003, Journal of Virology.

Genetic analysis of the complete gag and env genes of HIV type 1 subtype C primary isolates from South Africa.

S. Barnett, S. Engelbrecht, J. Z. Megede, 2001, AIDS research and human retroviruses.

Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins

D. Montefiori, T. Dubensky, D. Driver, 2005, Journal of Virology.

Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys.

R. Kurth, S. Norley, M. Baier, 1996, Virology.

Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs.

R. Kurth, K. Cichutek, S. Norley, 1996, Journal of biotechnology.